Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

“Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis”: Comment

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.02.032Source: DataRank Database

“Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis”: Comment is a research paper published in Journal of Thrombosis and Haemostasis (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.23)OA: bronzeTopics (28)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

Feras Abu Saadeh ORCID,Lucy A. Norris

Live enrichment

PubMed:37179077 OpenAlex:https://openalex.org/W4376155688

LEO Pharma

FWCI

0.23

Citation Percentile

0.5%

Citation Trend

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jthjournal.org/article/S1538783623002611/pdf

publisherhttp://www.jthjournal.org/article/S1538783623002611/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783623002611?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783623002611?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2023.02.032

Fields of Study

Venous Thromboembolism Diagnosis and ManagementAcute Myocardial Infarction ResearchBlood Coagulation and Thrombosis MechanismsHumansFemaleAnticoagulantsVenous ThromboembolismHemorrhageHospitalsOvarian NeoplasmsPostoperative Complications

MeSH Terms

AnticoagulantsFemaleHemorrhageHospitalsHumansOvarian NeoplasmsPostoperative ComplicationsVenous Thromboembolism

Keywords

MedicineVenous thromboembolismOvarian cancerScopusCancerGynecologyInternal medicineMEDLINEThrombosis

Sustainable Development Goals

SDG 0: Good health and well-being

“Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis”: Comment

FAIR Checklist

DataRank Breakdown

Authors (2)

Funding (1 grants)

Impact

Open Access

Topics